Arcus Biosciences Inc. (RCUS) Slipped -9.08% or -0.77 To Price $7.71 On Monday


Arcus Biosciences Inc. (RCUS) slipped -9.08% or -0.77 to $7.71. It is approximately 239575 shares traded, which is 240.67% compare to the average total volume 99544. The market cap of RCUS is $343.37 million. The year to date change is -29.68%. The 52 week price range is from $7.6 to $17.5. Price of RCUS have changed -5.36% during last week. It have changed -14.86% over last month, -29.33% over last 3 months, -33.80% over last 6 months and -47.49% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RCUS is 10.87. It is 40.99% above current price. The 200-day Moving Averages for RCUS is 11.55. It is 49.81% above current price. The 52-week High is 17.5. It is 126.98% from the current price. The 52-week Low is 7.6. It is -1.43% from current price.

There are some statistics of RCUS. It is has market cap $343.37 million. The share outstanding is 44.54 million. The average volume is 99544. The percent of top 15 Institution holding is 46.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RCUS is -22.25%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RCUS is -19.26%.


Tags:

Share this post